At $342.23, Arm Holdings (NASDAQ:ARM | ARM Price Prediction) appears fairly valued, with a more attractive entry point sitting at or below $310 on any macro-driven technical consolidation. The stock has become the cleanest pure-play on agentic AI infrastructure, but the round trip from $100 to $428 and back to the mid-$300s in six months argues for patience over chase.
Arm licenses the CPU architecture that powers virtually every smartphone on earth and is rapidly becoming the default compute platform inside hyperscale data centers. The company has shipped over 350 billion chips and counts AWS, Google, Microsoft, NVIDIA, and Meta as anchor customers. A 13.02% drop over the past week, set against a hawkish Warsh-led Fed signaling slower easing, has pulled long-duration tech back into focus.
The Bull Case: Agentic AI Demand Is Pulling Forward
Arm’s pivot from royalty rents on phones to dollar-rich data center silicon is real. Data center royalty revenue more than doubled year-over-year in Q4, and management disclosed more than $2 billion in customer demand for the new Arm AGI CPU across FY2027 and FY2028, with Meta signed as lead co-development partner for personal superintelligence workloads targeting 3+ billion users.
NVIDIA Vera, Google Axion, Microsoft Cobalt, and AWS Graviton all run Arm cores, and agentic AI requires more than 4x current CPU capacity per gigawatt. Annual contract value reached $1.66 billion, up 22% year-over-year, and the data center CPU TAM is projected at over $100 billion by 2030. Mizuho’s recent target hike to $500 reflects this re-rating.
The Bear Case: Valuation Has Lapped the Fundamentals
Arm trades at a trailing P/E of 357x and a forward P/E of 147x, with a price-to-sales ratio of 67x. Q1 FY2027 guidance implies sequential revenue of $1.26 billion with non-GAAP EPS of $0.40, and RPO decreased 7% year-over-year.
Non-GAAP R&D climbed 43% to $1.91 billion, compressing operating margin from 52.8% to 49.1%. The Qualcomm/Nuvia trial is expected in Q4 calendar 2026, SoftBank remains a controlling shareholder, and a beta of 3.79 means rate scares hit this name first.
The Hold Case: Right Story, Wrong Entry
The thesis is intact, but the chart is doing valuation discovery in real time. ARM ran 64.6% in a single month before giving back double digits last week. Buying inside that volatility band is a tactical decision rather than a strategic one.
The fair-value question hinges on whether AGI CPU shipments convert that $2 billion pipeline into recognized royalty revenue on schedule. Investors watching quarterly hyperscaler design-win cadence and royalty mix shift should let the Warsh Fed’s posture and post-Computex digestion drive price discovery.
What the Stock Is Actually Showing
ARM currently trades at $342.23 against a consensus analyst target of $254.87, implying roughly 25% downside from this level. Of 40 covering analysts, 7 rate it Strong Buy, 21 Buy, 10 Hold, and 2 Sell.
Year-to-date ARM is up 213.08% versus the S&P 500’s 8.19% gain. FY2026 closed with revenue of $4.92 billion, a third straight year above 20% growth, and free cash flow of $882 million.
Why $310 Is the Key Level
At $342, the risk/reward looks balanced for Arm Holdings.
The condition that improves the risk/reward is a controlled pullback to $310 zone on macro noise rather than company-specific deterioration. A Warsh Fed signaling fewer cuts, a hot CPI reading, or post-Computex profit-taking compress multiple without touching the AGI CPU order book. That is the entry both retail and institutions want.
The downside catalyst is different: a slip in AGI CPU production timing, a meaningful Qualcomm/Nuvia ruling against Arm, or a hyperscaler design-win loss to RISC-V. Absent those, the FY2027 royalty ramp is the gating event, and the next two quarterly reports will tell investors whether $342 was fair or a high-water mark.
The cost of patience here is small, while the cost of chasing a 64% one-month move into a hawkish Fed is meaningfully higher. Waiting for $310 captures the same multi-year AGI CPU thesis at a 10% better cost basis with materially less drawdown risk.
Top Gaining Stocks
Top Losing Stocks